Company: GRCE
Filing Date: 2025-04-09
Form Type: 8-K
Source: 0001140361-25-012944
Chunk: 0

Company: Grace Therapeutics, Inc.
Filing Date: 2025-04-09
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01      Other Events.  

On April 9, 2025, Grace Therapeutics, Inc. issued a press release announcing alignment with
the U. S. Food and Drug Administration supporting its planned New Drug Application submission for GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet medical needs in aneurysmal subarachnoid hemorrhage patients. A copy of the press release is
attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated by reference into this Item 8.01.